Search research articles
Contact Us
Filters
Showing results (441-450 of 453) with videos related to
Page
of 46
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 27, 2016
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Patrick Waters, Markus Reindl, Albert Saiz, et al.
Nature Communications
|
December 22, 2023
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Benedict D Michael, Cordelia Dunai, Edward J Needham, et al.
Nature Communications
|
April 4, 2024
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Benedict D Michael, Cordelia Dunai, Edward J Needham, et al.
Brain : a Journal of Neurology
|
May 15, 2023
The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD)
Nicholas M Allen, Mark O'Rahelly, Bruno Eymard, et al.
Neurology
|
July 3, 2020
Minimal manifestation status and prednisone withdrawal in the MGTX trial
Ikjae Lee, Hui-Chien Kuo, Inmaculada B Aban, et al.
Brain : a Journal of Neurology
|
July 9, 2020
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Ross W Paterson, Rachel L Brown, Laura Benjamin, et al.
The Lancet. Neurology
|
January 30, 2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
The New England Journal of Medicine
|
August 11, 2016
Randomized Trial of Thymectomy in Myasthenia Gravis
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
Nature Medicine
|
September 23, 2024
Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction
Greta K Wood, Brendan F Sargent, Zain-Ul-Abideen Ahmad, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 28, 2017
Incidence and prevalence of NMOSD in Australia and New Zealand
Wajih Bukhari, Kerri M Prain, Patrick Waters, et al.
Page
of 46
Search research articles
Search
Showing results (441-450 of 453) with videos related to
Sort By:
Page
of 46
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 27, 2016
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Patrick Waters, Markus Reindl, Albert Saiz, et al.
Nature Communications
|
December 22, 2023
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Benedict D Michael, Cordelia Dunai, Edward J Needham, et al.
Nature Communications
|
April 4, 2024
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Benedict D Michael, Cordelia Dunai, Edward J Needham, et al.
Brain : a Journal of Neurology
|
May 15, 2023
The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD)
Nicholas M Allen, Mark O'Rahelly, Bruno Eymard, et al.
Neurology
|
July 3, 2020
Minimal manifestation status and prednisone withdrawal in the MGTX trial
Ikjae Lee, Hui-Chien Kuo, Inmaculada B Aban, et al.
Brain : a Journal of Neurology
|
July 9, 2020
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Ross W Paterson, Rachel L Brown, Laura Benjamin, et al.
The Lancet. Neurology
|
January 30, 2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
The New England Journal of Medicine
|
August 11, 2016
Randomized Trial of Thymectomy in Myasthenia Gravis
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
Nature Medicine
|
September 23, 2024
Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction
Greta K Wood, Brendan F Sargent, Zain-Ul-Abideen Ahmad, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 28, 2017
Incidence and prevalence of NMOSD in Australia and New Zealand
Wajih Bukhari, Kerri M Prain, Patrick Waters, et al.
Page
of 46